MHRA lays out its thinking on AI and medicines regulation
An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
Newsletters and Deep Dive digital magazine
An MHRA document explaining how regulations will adapt to the era of AI and personalised medicine has been well received by the pharma industry.
Zealand has added another strand to its programme of weight-loss drug development, linking with AI player Generate on multispecific protein therapies.
Robbie Tyrie, founder and managing director of Torridon Cyber, talks cybersecurity when it comes to AI, pharma companies, and health systems.
As AI becomes embedded throughout development, innovation must be matched by equally sophisticated approaches to software security.
September brought leadership changes across businesses providing technology, research, manufacturing, and professional services to the life sciences.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks